Sideris Pharmaceuticals
About:
Sideris Pharmaceuticals is focused on the development of therapeutics for the treatment of transfusion-related iron overload.
Website: http://www.siderispharma.com
Top Investors: MPM Capital, OUP (Osage University Partners), Hatteras Venture Partners
Description:
Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL.
Total Funding Amount:
$32.6M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Lexington, Massachusetts, United States
Founded Date:
2012-01-01
Founders:
Raymond Bergeron, Thomas Neenan
Number of Employees:
11-50
Last Funding Date:
2013-10-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai